Sr One Capital Management, LP
SEC-registered investment adviser.
- Website
- https://www.srone.com/
- HQ
- CA
Sr One Capital Management is a biotechnology venture capital firm. It partners with founders and entrepreneurs to turn innovative science into medicines.
01 · Says / Does
| Tag | Says | Does | Historically (to 2020) |
|---|---|---|---|
| Stages | Not stated | Not enough dated deals | Growth, Series B, Series A |
| Sectors | Biotech | Not enough dated deals | Biotech, Healthtech, Medical devices, Life sciences and research tools |
| Regions | US, Global | Not enough dated deals | MA, CA |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
Historical focus (through 2020), derived from historical deal data.
| Year | Deals | Top sectors |
|---|---|---|
| 1997 | 1 | Biotech, Healthtech |
| 1999 | 2 | Biotech, Devtools, Healthtech |
| 2000 | 2 | Biotech, Healthtech, Medical devices |
| 2001 | 1 | Biotech, Healthtech |
| 2002 | 4 | Biotech, Healthtech, Advanced materials |
| 2003 | 4 | Biotech, Healthtech, Enterprise SaaS |
| 2004 | 1 | Biotech, Healthtech |
| 2005 | 5 | Biotech, Healthtech, Advanced materials |
| 2006 | 7 | Biotech, Healthtech, Manufacturing |
| 2007 | 6 | Healthtech, Biotech, Life sciences and research tools |
| 2008 | 2 | Biotech, Healthtech |
| 2009 | 10 | Biotech, Healthtech, Life sciences and research tools |
| 2010 | 7 | Biotech, Healthtech, Medical devices |
| 2011 | 7 | Biotech, Healthtech, Medical devices |
| 2012 | 9 | Biotech, Healthtech, Medical devices |
| 2013 | 8 | Biotech, Healthtech, Medical devices |
| 2014 | 12 | Biotech, Healthtech, Life sciences and research tools |
| 2015 | 18 | Biotech, Healthtech, Medical devices |
| 2016 | 9 | Biotech, Healthtech, Medical devices |
| 2017 | 9 | Biotech, Healthtech, Medical devices |
| 2018 | 10 | Biotech, Healthtech, Medical devices |
| 2019 | 3 | Biotech, Healthtech, Life sciences and research tools |
| 2020 | 3 | Biotech, Healthtech, Life sciences and research tools |
Stage mix over time
- Pre-seed
- Seed
- Series A
- Series B
- Growth
| Year | Pre-seed | Seed | Series A | Series B | Growth |
|---|---|---|---|---|---|
| 2010 | 0 | 1 | 0 | 5 | 1 |
| 2011 | 0 | 0 | 2 | 2 | 2 |
| 2012 | 0 | 0 | 3 | 2 | 3 |
| 2013 | 0 | 0 | 3 | 1 | 3 |
| 2014 | 0 | 3 | 4 | 3 | 2 |
| 2015 | 0 | 0 | 8 | 6 | 3 |
| 2016 | 0 | 0 | 3 | 3 | 3 |
| 2017 | 0 | 0 | 1 | 3 | 5 |
| 2018 | 0 | 0 | 2 | 2 | 4 |
| 2019 | 0 | 0 | 1 | 2 | 0 |
| 2020 | 0 | 0 | 1 | 2 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 |
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| SR One Capital Fund III, LP SR One is a biotechnology venture capital firm that partners with founders and entrepreneurs to translate innovative science into medicines. It takes a back-and-build approach, focusing on companies with strong fundamentals, a clearly defined development pathway, and novel approaches to disease. Inferred from the firm's website | 2024 | $247.33M to $600M (Form D) | Open, writing first checks |
03 · People across funds
- Rajeev Dadoo
SR One Capital Fund III, LP (Named on Form D)
- Simeon George
SR One Capital Fund III, LP (Named on Form D)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026